A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

Clinical trial NCT06798298 · RECRUITING

Trial details

NCT number: NCT06798298
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Long Term Safety Following GM T Cell Therapy

Start date: 2025-11-10
Primary completion: 2040-06-17
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.